Detalhe da pesquisa
1.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A
; 116(2): 619-624, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30584090
2.
Validation of an enhanced recovery after surgery protocol in gynecologic surgery: an Italian randomized study.
Am J Obstet Gynecol
; 223(4): 543.e1-543.e14, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32652064
3.
Laparoscopic management of a large urethral leiomyoma.
Int Urogynecol J
; 30(7): 1211-1213, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756139
4.
Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.
Int J Gynecol Cancer
; 27(1): 28-36, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870700
5.
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study.
Anticancer Res
; 40(3): 1543-1550, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132055
6.
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients.
Front Oncol
; 10: 584022, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33134179
7.
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients.
Front Oncol
; 10: 1287, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850397
8.
Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Anticancer Res
; 38(6): 3627-3634, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848719
9.
Prognostic factors in early-stage ovarian cancer.
Ecancermedicalscience
; 7: 325, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23781280